Attendee search 

Topscience is specializing in chemical and biological res earch product and service to meet the research needs of global customers. We offers over 80 types of compound liberties and a wide range of high-quality research chemical including inhibitors.，activator， natural compounds，peptides,inhibitory antibodies，and novel life-science kits, for laboratory and scientific use.Besifdes,virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

focus on biotech,IVD

Takeda Pharma

Swissaustral is a worldwide specialist in Extreme Biotechnology developing innovative solutions for non-standard technological challenges in Life Sciences and different areas of Industry. Our company exploits the potential of extremophilic microorganisms and their unexplored metabolic pathways as a unique and diverse natural source for biocompounds of various industrial applications going from pharmaceutical, chemical, food and biotechnology.

CTTQ is a leading big pharma with integrated R&D, manufacturing, marketing, and sales in China. We are the markter leader in drugs treating liver disease and cancer in China. CTTQ is a subsidiary of Sino Biopharmaceutical Ltd., which has been listed on Hong Kong Stock Exchange since 2003. Currently CTTQ has more than 10,000 employees, with total revenue of RMB 23 billion (USD$3.2 B) in 2019.

We are looking for cooperation opportunities with pharma/biotech companies via licensing and R & D collaboration in the following areas: Innovative small molecule and biologics products in therapeutic areas of oncology, liver, infectious, respiratory, cardiovascular, and metabolic diseases, etc.

Yngzijiang Pharmaceutial Group is an integrated healthcare company in china, our business scope ranges from Pharma(small molcules，biological and TCM), Medical Device and consumer health products. With nearly 20000 employees around the world. We are the biggest private Pharmaceutial company by revenue in China, with a strong revenue growth rate in the past decade. We are open to any coopearation opportunities globally. Welcome to talk to us.

Usurpo are a UK based specialist search firm focused on helping high-growth Life Sciences businesses hire outstanding executives worldwide. We have successfully run search campaigns in EMEA, ASIA PAC, India and the US.

We work closely with Pharmaceutical, Biotechnology, Medical Device companies and service providers to help them build exceptional leadership teams, particularly across Europe and the US. We have a track record of helping international business from China, Japan, Israel and Korea make key hires in the US and Europe for their expanding international teams.

We help our clients to hire Senior Director, VP and C-suite level professionals into the following areas:

- Clinical Development (Chief Medical Officer, Chief Development Officer, Medical Director, Therapeutic area experts)
- Regulatory Affairs
- CMC
- Business Development (Licensing, M&A, Corporate Development)
- Business Development (Sales and business expansion for service providers)
- Cross functional C-suite leadership
- Sales and Marketing leaders

MedSci Healthcare was established in 2002 with the creation of Bioon.com, with headquarters in Shanghai and internationally in the U.S. We are committed to be the bridge between China and the U.S. healthcare. This is done by connecting Chinese healthcare professionals (HCPs) with U.S. resources and vice versa.
The company has done projects with major companies such as: Pfizer, Harvard Medical School, AstraZeneca, GSK, Abbott, Johnson & Johnson, Takeda, Novartis, Medtronic and many more. We have also worked with organizations such as the China Cardiovascular Association (CCA), Chinese Medical Doctor Association (CMDA) and more.
MedSci is a digital academic platform, scientific publishing support and multichannel marketing (MCM) organization. We use the term Academic Promotion Organization (APO). We use scientific writers, doctors & researcher scientists and commercialization experts to develop customized strategy & implementation to reach each organization’s goals.

Adagene, Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.